Track the 차백신연구소 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 차백신연구소 has logged 30 public disclosures. Market capitalisation: €60.7bn. The latest transaction was filed on 11 May 2026 (Sale). Among the most active insiders: 고정재. Every trade is openly available.
30
Insider Decl.
n/a
Thresholds
€39m
7 ops.
Buy Volume
€23m
8 ops.
Sell Volume
22Σ signal
Buys €39m€23m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,638 of 29,064 companies
29.8
score / 100
Value
10
Quality
49
FCF yld-17%
Earn yld-24%
EV/EBITDA·
ROE-89%
Gross mgn91%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.